We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SBK:JSEStandard Bank Group Limited Analysis

Data as of 2026-05-27 - not real-time

ZAC 32,197.00

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Valuation appears attractive with a trailing P/E of 10.78 versus an industry average of 16.60, and a forward P/E of 8.88, suggesting the stock is undervalued. The dividend yield stands at 5.47% with a payout ratio around 53%, reinforcing the case for income‑focused investors. Technicals are supportive: the price of 32,197 sits above the 20‑day (31,054) and 50‑day (31,095) SMAs, the MACD histogram is strongly positive and the RSI at 61 indicates room for further upside without being overbought. Insider activity adds confidence, as insiders have added roughly R66 million of stock over the past year, signaling belief in the company’s prospects.
The bank delivers solid profitability—operating margin of 43% and profit margin of 28%—and revenue is growing at 9% YoY, while the beta of ~0.2 (computed) and a volatility of ~23% point to relatively low market risk. However, operating cash flow is negative, which tempers the outlook, and volume trends are decreasing, suggesting caution on short‑term liquidity. Overall, the combination of attractive valuation, robust dividend, and supportive technical momentum makes SBK a compelling hold with upside potential, especially if the price can break the resistance around 32,299.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near resistance at 32,299
  • Decreasing volume trend
  • Bullish MACD but limited immediate upside

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervalued P/E relative to peers
  • Strong dividend yield and sustainable payout
  • Insider buying indicating confidence

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Consistent profitability and 9% revenue growth
  • Low beta and modest volatility
  • Attractive dividend and potential for capital appreciation

Key Metrics & Analysis

Financial Health

Revenue Growth9.00%
Profit Margin28.38%
P/E Ratio10.8
ROE18.73%
ROA1.64%
P/B Ratio1.8
Op. Cash FlowZAC-225887993856
Industry P/E16.6

Technical Analysis

TrendNeutral
RSI61.4
SupportZAC 29,540.00
ResistanceZAC 32,299.00
MA 20ZAC 31,053.55
MA 50ZAC 31,095.06
MA 200ZAC 28,207.88
MACDBullish
VolumeDecreasing
Fear & Greed Index91.29

Valuation

Target PriceZAC 33,677.00
Upside/Downside4.60%
GradeUndervalued
TypeBlend
Dividend Yield5.47%

Risk Assessment

Beta0.20
Volatility22.86%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.